2018 Update on Pediatric Medical Overuse: A Review.


Journal

JAMA pediatrics
ISSN: 2168-6211
Titre abrégé: JAMA Pediatr
Pays: United States
ID NLM: 101589544

Informations de publication

Date de publication:
01 04 2019
Historique:
pubmed: 19 2 2019
medline: 13 2 2020
entrez: 19 2 2019
Statut: ppublish

Résumé

Efforts to combat medical overuse have gained traction in recent years, but success has been intermittent and shortcomings have been recognized. A commitment to a strong evidence base is needed to more broadly engage clinicians and reduce overuse. A structured MEDLINE search and a manual review of tables of contents from selected high-impact journals was performed to identify original research published in 2017 relevant to pediatric overuse. Articles were scored from low to high for 3 categories: quality of methods, magnitude of potential harm, and number of patients potentially harmed. The top-scoring articles presented in this review highlight examples of safe reductions in treatment intensity, including in the setting of cancer, appendicitis, acute respiratory tract infection, and elective anesthesia. This year's articles also provide cautionary examples of rational interventions adopted without a full understanding of potential harms, including pharmacologic migraine therapies, docosahexaenoic acid supplementation for preterm neonates, tight glycemic control for individuals with critically illness, and prophylactic antibiotics for children with vesicoureteral reflux. The articles represent high-quality, original research from 2017 that may help mitigate overuse. These works should be fundamental to the maturation of the pediatric overuse field.

Identifiants

pubmed: 30776069
pii: 2725043
doi: 10.1001/jamapediatrics.2018.5550
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

379-384

Auteurs

Eric R Coon (ER)

Department of Pediatrics, University of Utah School of Medicine, Primary Children's Hospital, Salt Lake City.

Ricardo A Quinonez (RA)

Section of Pediatric Hospital Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.

Daniel J Morgan (DJ)

University of Maryland School of Medicine, Baltimore.
Veterans Affairs Maryland Healthcare System, Baltimore.

Sanket S Dhruva (SS)

University of California, San Francisco, School of Medicine and San Francisco VA Healthcare System, San Francisco.

Timmy Ho (T)

Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Nathan Money (N)

Section of Pediatric Hospital Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.

Alan R Schroeder (AR)

Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH